Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 67, Issue 3, 1999, Pages 323-328

  Dujardin, Kathy ^a,b   Duhamel, Alain ^c   Becquet, Estelle ^a   Grunberg, Christine ^a   Defebvre, Luc ^a   Destee, Alain ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c Faculté de Médecine Pôle Recherché   (France)

Author keywords

Executive function; Parkinson's disease; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; EARLY DIAGNOSIS; FAMILIAL DISEASE; FEMALE; GENETIC ANALYSIS; HUMAN; MALE; NEUROPSYCHOLOGY; NEURORADIOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0032800551     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.67.3.323     Document Type: Article

References (46)

1. Langston JW, Ballard P, Tetrrud JW, et al. Parkinsonism due to a product of meperidine-analog synthesis. Science 1983;219:979-80
2. Golbe LJ, Di Iorio G, Bonavita V, et al. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 1990; 27:276-82.
3. Waters CH, Miller CA. Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann Neurol 1994;35:59-64.
4. Wszolek ZK, Pfeiffer B, Fulgham JR, et al. Western Nebraska family (family D) with autosomal dominant Parkinson's disease. Ann Neurol 1993;34:264.
5. Marcopoulou K, Wszolek ZK, Pfeiffer RF. A Greek-American kindred with autosomal, levodopa responsive parkinsonism and anticipation. Ann Neurol 1995;38:373-8.
6. Polymeropoulos MH, Higgins JJ, Golbe LI, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996;274:1197-9.
7. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synucleine gene identified in families with Parkinson's disease. Science 1997;276:2045-7.
8. Gasser T, Müller-Myhsok B, Zbigniew K, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18:262-5.
9. Holthoff VA, Vieregge P, Kessler J, et al. Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 1994;36:176-82.
10. Sawle GV, Wroe SJ, Lees AJ, et al. The identification of presymptomatic parkinsonism: clinical and 18F dopa positron emission tomography studies in an Irish kindred. Ann Neurol 1992;32:609-17.
11. 18F-dopa positron emission tomography study. Ann Neurol 1997;41:222-9.
12. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983;106:257-70.
13. Brown RG, Marsden CD. Internal versus external cues and the control of attention in Parkinson's disease. Brain 1988; 111:323-45.
14. Brown RG, Marsden CD. Dual task performance and processing resources in normal subjects and patients with Parkinson's disease. Brain 1991;114:215-31.
15. Pillon B, Dubois B, Agid Y. Testing cognition may contribute to the diagnosis of movement disorders. Neurology 1996;46:324-34.
16. Owen AM, Iddon JL, Hodges JR, et al. Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia 1997;35:519-32.
17. Dubois B, Malapani C, Verin M, et al. Fonctions cognitives et Noyaux Gris Centraux: le modèle de la maladie de Parkinson. Rev Neurol (Paris) 1994;150:763-70.
18. Gibb WRG, Lees A. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-52.
19. Lazzarini AM, Myers RH, Zimmerman TR, et al. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 1994;44:499-506.
20. Golbe LJ, Di Iorio G, Sanges J, et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1996;40:767-75.
21. Schmidt R, Friedl W, Fazekas F, et al. The Mattis dementia rating scale: normative data from 1001 healthy volunteers. Neurology 1994;44:964-6.
22. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasy TE, eds. Geriatric psychiatry. New York: Gruse and Stratton, 1976:77-121.
23. Wechsler D. Wechsler adult intelligence scale-revised manual. New York: Psychological Corporation, 1981.
24. Nelson HE. A modified card sorting test sensitive to frontal lobe defect. Cortex 1976;12:313-24.
25. Owen AM, Sahakian BJ, Hodges JR, et al. Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease. Neuropsychology 1995;9:126-40.
26. Brown J. Some tests of the decay theory of immediate memory. Q J Exp Psychol 1958;10:12-21.
27. Peterson LR, Peterson MJ. Short term retention of individual verbal items. J Exp Psychol 1959;58:193-8.
28. Luria AR. Les fonctions corticales supérieures de l'homme. Paris: PUF, 1978.
29. Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968;6:53-60.
30. Pillon B, Dubois B, Bonnet AM, et al. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: The 15-objects test. Neurology 1989;39:762-8.
31. SAS Tests. Cary, NC: SAS Institute, 25513.
32. Dibley MJ, Staehling N, Nieburg P, et al. Interpretation of Z-score anthropometric indicators derived from the international growth reference. Am J Clin Nutr 1987;46: 749-62.
33. Kiernan RJ, Matthews CG. Impairment versus T-score averaging in neuropsychological assessment. J Consult Clin Psychol 1976;44:951-7.
34. Jason GW, Suchowersky O, Pajurkova EM, et al. Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. Arch Neurol 1997;54:1081-8.
35. Duffy JD, Campbell JJ. The regional prefrontal syndromes: a theoretical and clinical overview. J Neuropsychiatry Clin Neurosci 1994;6:379-87.
36. Owen AM, Roberts AC, Hodges JR, et al. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 1993;116:1159-75.
37. Owen AM, Doyon J, Petrides M, et al. Planning and spatial working memory: a positron emission tomography study in humans. Eur J Neurosci 1996;8:353-64.
38. Owen AM, Evans AC, Petrides M. Evidence for a two-stage model of spatial working memory processing within the lateral frontal cortex: a positron emission tomography study. Cereb Cortex 1996;6:31-8.
39. Taylor AK, Saint-Cyr JA. Executive functioning. In: Huber SJ, Cummings JL, eds. Parkinson's disease. Neurobehavioral aspects. New York: Oxford University Press, 1992:74-85.
40. Cronin-Golomb A, Corkin S, Growdon JH. Impaired problem solving in Parkinson's disease: impact of a set-shifting deficit. Neuropsychologia 1994;32:579-93.
41. Norman DA, Shallice T. Attention to action. Willed and automatic control of behavior. San Diego, CA: University of California, 1980. (CHIP report No 99.)
42. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-301.
43. 18F-dopa PET and clinical study of the rate of the progression in Parkinson's disease. Brain 1996;119:585-91.
44. Koller WC. When does Parkinson's disease begin? Neurology 1992;42(suppl 4):27-31.
45. Vingerhoets FJG, Snow BJ, Lees CS, et al. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic Parkinson's disease. Ann Neurol 1994;36:759-64.
46. Hoehn MM, Yahr MD Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-12.